Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ --Â Cypherpunk Technologies Inc., previously known as…
Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy
Khing Oei appointed Chairman of the Board; Will McEvoy appointed Chief Investment…
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary…
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in…
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET Â | Source: Intellia Therapeutics, Inc. Deep, stable…
Hyundai Motor Group and CuspAI Partner to Accelerate Material Innovation Using AI
Hyundai Motor Group and CuspAI announce a strategic partnership to accelerate the…
INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community
Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug…
Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease
In Canada, lecanemab is indicated for the treatment of adult patients with…
Internet Watch Foundation and Public Interest Registry Extend Online Safety Initiative to Disrupt Criminal ‘brands’ Selling Child Sexual Abuse
A new sponsorship programme aims to help domain registrars 'disrupt' criminal businesses…
MIT Technology Review’s EmTech MIT 2025: Leading with Transformative Technology
MIT's flagship conference returns November 4–6 to explore how to lead with…